Navigating Tx of Bipolar Disorder in Pregnancy

Ob Gyn News ◽  
2005 ◽  
Vol 40 (3) ◽  
pp. 11
Author(s):  
DIANA MAHONEY
2020 ◽  
Vol 66 (3) ◽  
pp. 225-231 ◽  
Author(s):  
Liana Suparare ◽  
Stuart J Watson ◽  
Ray Binns ◽  
Jacqueline Frayne ◽  
Megan Galbally

Objective: To examine the risk of past and current experiences of intimate partner violence (IPV) in women with severe mental illness (SMI) in pregnancy. Methods: We examined past and current experiences of IPV in women with SMI in pregnancy. The data of 304 women with SMI including schizophrenia and related psychotic disorders and Bipolar Disorder meeting International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM) criteria were extracted from hospital records at King Edward Memorial Hospital, Western Australia. Comparisons were made between our study data and the Australian population data reported by the Australian Bureau of Statistics, which included data on pregnant women in Western Australia. Additional measures included reported demographics, substance use and pregnancy variables. Results: Around 48% of pregnant women with SMI had experienced IPV and were three times the risk when compared with the general pregnant population in Australia. There was no difference in rates of IPV in those women with psychotic disorders when compared with bipolar disorder. Furthermore, the rates of smoking and illicit substance use were significantly higher in pregnant women with SMI who experienced IPV compared with those who have not experienced IPV. Conclusion: These findings suggest women with SMI in pregnancy are at significantly higher risk of having experienced or experiencing IPV. In addition, IPV in pregnant women with SMI may increase the risk of smoking and illicit substance use. Together this suggests that maternity and mental health services should ensure there are both screening and support pathways for IPV that are developed and evaluated specifically for pregnant women with SMI.


The Lancet ◽  
2014 ◽  
Vol 384 (9956) ◽  
pp. 1789-1799 ◽  
Author(s):  
Ian Jones ◽  
Prabha S Chandra ◽  
Paola Dazzan ◽  
Louise M Howard

2013 ◽  
Vol 3 (2) ◽  
pp. 83-87 ◽  
Author(s):  
Thea Moore ◽  
Jennifer Pytlarz

Though approximately 15 to 29% of pregnant patients have a psychiatric disorder during pregnancy, only about 5 to 14% seek treatment. Untreated mental illness during pregnancy has been associated with poor nutrition, failure to follow prenatal and medical guidelines, and alcohol or other substance misuse. The risks of untreated mental illness during pregnancy must be carefully evaluated along with the risks posed by medications. This review will evaluate consequences of untreated depression, anxiety, schizophrenia, and bipolar disorder in the pregnant patient.


10.5080/u6131 ◽  
2010 ◽  
Author(s):  
Sinan Guloksuz ◽  
Fisun Akdeniz ◽  
Bahri Ince ◽  
Esat Timucin Oral

2019 ◽  
Vol 49 (9) ◽  
pp. 392-398
Author(s):  
Andrea Favini ◽  
Sarah Homitsky

2015 ◽  
Vol 45 (8) ◽  
pp. 411-416
Author(s):  
Leena Mittal ◽  
Christina L. Wichman ◽  
Nancy Byatt

2018 ◽  
Author(s):  
Tiffany A. Moore Simas ◽  
Bailey McGuiness ◽  
Valerie Valant ◽  
Nancy Byatt

Perinatal depression includes major and minor depression occurring in pregnancy and one year postpartum. Affecting one in seven women, it is one of the most common pregnancy complications; however, it is often under recognized and undertreated. A personal history of perinatal or non-perinatal depression significantly increases risk. Screening using a validated instrument is recommended in the context of systems to ensure effective diagnosis, treatment, and follow-up. Evidence-based treatment includes psychotherapy and pharmacotherapy. Selective serotonin reuptake inhibitors are well-studied in pregnancy, are associated with low overall absolute risk, and are differentially secreted into breast milk. If left untreated, perinatal depression is associated with significant short- and long-term negative maternal-child consequences including, among many others things, poor bonding. Of note, maternal suicide exceeds hemorrhage and hypertensive disorders as a cause of maternal mortality. It is critical to recognize that one in five women who screen positive for perinatal depression will have bipolar disorder and are at highest risk for postpartum psychosis, suicide, and infanticide, especially if prescribed unopposed anti-depressant monotherapy. Women who screen positive for having bipolar disorder should be referred for psychiatric evaluation. This review contains 6 figures, 13 tables and 54 references Keywords: Pregnancy, Postpartum, Perinatal, depression, Mood disorder, Baby blues, Bipolar disorder, Psychosis, Psychotherapy, Psychopharmacology


Sign in / Sign up

Export Citation Format

Share Document